Morocco vs Tajikistan: Access to anti-retroviral drugs, female
Morocco
93.0%
in 2024
Tajikistan
95.0%
in 2024
Morocco rank
22nd
Tajikistan rank
19th
Access to anti-retroviral drugs, female over time
- Morocco
- Tajikistan
How they compare
Tajikistan currently reports 95.0% against 93.0% in Morocco, a difference of 2.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Tajikistan ahead.
Morocco ranks 22nd and Tajikistan ranks 19th of 141 countries.
Across the 3 decades both report, Morocco averaged higher in 2 and Tajikistan in 1.
Head to head by decade
| Decade | Morocco | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.0% | 0.7% | 5.3% | Morocco |
| 2010s | 38.3% | 29.8% | 8.5% | Morocco |
| 2020s | 82.2% | 83.4% | 1.2% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Morocco or Tajikistan?
- Tajikistan, at 95.0% against 93.0% in Morocco as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Morocco and Tajikistan?
- 2.0%, with Tajikistan ahead.
- How many years of comparable data are there for Morocco and Tajikistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Morocco and Tajikistan rank globally for access to anti-retroviral drugs, female?
- Morocco ranks 22nd and Tajikistan ranks 19th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.